MDHearing Volt vs RCA In-Ear

The MDHearing Volt is a budget-priced prescription hearing aid available for $397, earning a B grade with a SoundScore of 3.1/5 in our lab testing. This behind-the-ear, rechargeable device ranks #32 of 36 prescription hearing aids tested, placing it in the top 86% of its category. In our standardized testing, the Volt demonstrates excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. This represents a genuine strength, as the device remained stable under our challenge protocols without audible squealing or whistling. However, speech performance presents significant limitations: speech in quiet scored 1.8/5 (1.57 points below the category average of 3.32), while speech in noise scored 1.0/5 (0.96 points below the 1.96 average). Own-voice comfort measured 2.6/5, a mixed result that falls 0.15 points below the category average. Music streaming is notably limited at 0.0/5, scoring 2.64 points below the category average—users prioritizing phone streaming should consider alternatives. The Volt showed no improvement between Initial and Tuned fits, with both configurations yielding identical scores of 3.1/5. The MDHearing Volt may suit budget-conscious consumers who prioritize basic amplification and excellent feedback stability over speech clarity or streaming features. However, shoppers in this price range should note that alternatives like the RxEars Rxi offer substantially higher performance at similar pricing.

The RCA In-Ear is a budget OTC hearing aid priced at $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC category at #64 of 65 devices tested. Speech performance is a significant weakness for this device. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, while speech in noise also scores 1.0/5, sitting 0.48 points below average. These low absolute scores indicate limited benefit for understanding conversation in most listening situations. Music streaming scored 0.0/5, measuring 1.92 points below the category average—this device is not suitable for audio entertainment. The RCA In-Ear does show strength in feedback handling, scoring an excellent 5.0/5, which is 0.46 points above the category average. Own-voice comfort is mixed at 2.6/5, essentially matching the category average with only a 0.09-point advantage. The rechargeable battery design offers convenience for daily use. At this price point, consumers have substantially higher-performing alternatives. Devices like the Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and several others in the same budget range deliver meaningfully better speech clarity and overall sound quality. The RCA In-Ear may appeal to those prioritizing feedback-free operation above all else, but most users seeking improved hearing will find better value elsewhere in the OTC market.